Aggression, Conduct Disorder Could Be Pediatric Drug Development Targets
Executive Summary
FDA is considering whether studies of pharmaceuticals to treat aggression in children would be appropriate, the agency told the Anti-Infective Drugs Advisory Committee's Pediatric Subcommittee Sept. 11.